Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter

Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis

(2018) Cyrielle Caussy et al.   HEPATOLOGY

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

(2017) Thomas Karlas et al.   JOURNAL OF HEPATOLOGY

Clinical implications of controlled attenuation parameter in a health check-up cohort

(2017) Min-Sun Kwak et al.   LIVER INTERNATIONAL

Nonalcoholic Fatty Liver Disease Is Associated With Coronary Artery Calcification Development: A Longitudinal Study

(2016) Hyo Eun Park et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Correlation of the controlled attenuation parameter with indices of liver steatosis in overweight or obese individuals

(2015) Giovanna Ferraioli et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

(2015) Raymond Kwok et al.   GUT

Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification

(2015) Seng Chan You et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study

(2015) Jessica L. Mellinger et al.   JOURNAL OF HEPATOLOGY

Nonalcoholic Fatty Liver Disease as a Risk Factor of Arterial Stiffness Measured by the Cardioankle Vascular Index

(2015) Goh Eun Chung et al.   MEDICINE

Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT

(2015) Kazuhiro Osawa et al.   PLoS One

High-Risk Coronary Plaque at Coronary CT Angiography Is Associated with Nonalcoholic Fatty Liver Disease, Independent of Coronary Plaque and Stenosis Burden: Results from the ROMICAT II Trial

(2015) Stefan B. Puchner et al.   RADIOLOGY

Nonalcoholic Fatty Liver Disease Is Associated with the Presence and Morphology of Subclinical Coronary Atherosclerosis

(2015) Min Kyoung Kang et al.   YONSEI MEDICAL JOURNAL

Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography

(2013) Eva Recio et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Diagnosis and Management of Nonalcoholic Fatty Liver Disease and Its Hemostatic/Thrombotic and Vascular Complications

(2013) Christopher Byrne et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

(2012) Naga Chalasani et al.   GASTROENTEROLOGY

Determination of reliability criteria for liver stiffness evaluation by transient elastography

(2012) Jérôme Boursier et al.   HEPATOLOGY

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

(2012) Victor Lédinghen et al.   LIVER INTERNATIONAL

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

(2012) Robert P. Myers et al.   LIVER INTERNATIONAL

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Comparison of the Relation Between the Calcium Score and Plaque Characteristics in Patients With Acute Coronary Syndrome Versus Patients With Stable Coronary Artery Disease, Assessed by Computed Tomography Angiography and Virtual Histology Intravascular Ultrasound

(2011) Joëlla E. van Velzen et al.   AMERICAN JOURNAL OF CARDIOLOGY

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease

(2011) V. W.-S. Wong et al.   GUT

General and abdominal obesity and abdominal visceral fat accumulation associated with coronary artery calcification in Korean men

(2010) Su-Yeon Choi et al.   ATHEROSCLEROSIS

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

(2010) S. McPherson et al.   GUT

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease

(2010) Nimer Assy et al.   RADIOLOGY

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

The Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans

(2009) Su-Yeon Choi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual histology intravascular ultrasound study

(2009) Takashi Kubo et al.   CORONARY ARTERY DISEASE

Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease

(2009) George V. Papatheodoridis et al.   JOURNAL OF HEPATOLOGY

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

(2008) G. Targher et al.   DIABETOLOGIA

Fatty Liver

(2007) Anna Kotronen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY